Cubebio Co., Ltd has confirmed the effectiveness of its recent SEC filing, a crucial development for the company and its stakeholders. This filing is an important regulatory step that may influence the surgical and medical instruments industry.
The company, Cubebio Co., Ltd, operates in the surgical and medical instruments sector. Its Central Index Key (CIK) is 0002058594. The recent filing was made on October 19, 2026, and is part of ongoing compliance efforts.
The filing states, "The effectiveness date is October 19, 2026," indicating that the company is moving forward with its plans as per the SEC regulations. This filing is linked to CubeBio Holdings Ltd, which has a separate CIK of 0002058261.
This development may affect various stakeholders, including investors, regulatory bodies, and other companies in the surgical and medical instruments industry. As the industry evolves, companies may need to adapt to regulatory changes and market dynamics.
The filing does not say what happens next, leaving stakeholders to anticipate further updates from Cubebio Co., Ltd.
Company Details
Cubebio Co., Ltd is registered under the Central Index Key (CIK) number 0002058594, while its affiliated entity, CubeBio Holdings Ltd, holds a separate CIK of 0002058261. Both companies are classified under the Standard Industrial Classification (SIC) for Surgical & Medical Instruments & Apparatus, specifically designated as 3841.
The filing indicates that both companies are located outside the United States, with Cubebio Co., Ltd's business address listed as 8F Shinhan Life Bldg, Digital-ro 10-gil, Geumcheon-gu, Seoul, M5. The business phone number provided is 82-70-4607-3799.
Filing Context
This filing is part of the compliance under the Securities Act of 1933, specifically identified by SEC file number 333-298262-01. The effectiveness date of October 19, 2026, marks a significant milestone for the company in its regulatory journey.
The filing does not provide additional details regarding future plans or specific implications of this effectiveness on the company's operations or strategy.